secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProSomnus, Inc. (—)
CIK:        0001934064
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001104659-24-062291
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProSomnus Q1 revenue $7.5M (+28% YoY) but files Chapter 11 restructuring
------------------------------------------------------------------------

- Q1 revenue $7.5M, up 28% YoY from $5.8M.
- Filed Chapter 11 restructuring on May 7; expects $20M new capital, ~60% debt reduction, return to private.
- RPMO 2 device expected to begin clinical testing before FDA submission in June 2024.
- Customer on-time deliveries above 99%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1934064/000110465924062291/0001104659-24-062291-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1934064/000110465924062291/tm2414698d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-062291

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer